Literature DB >> 9385561

Molecular modeling of CD28 and three-dimensional analysis of residue conservation in the CD28/CD152 family.

J Bajorath1, W J Metzler, P S Linsley.   

Abstract

CD28/CD152-CD80/CD86 receptor-ligand interactions result in costimulatory signals critical for optimal T cell activation. CD28/CD152 and CD80/CD86 are members of the immunoglobulin superfamily (IgSF). Despite common receptor-ligand interactions, both receptor and ligand pairs share only limited sequence identity. A detailed molecular model of the extracellular Ig-like domain of human CD28 was constructed using a combination of different modeling methods. The model was based on the solution structure of CD152 and sequence comparison of the CD28/CD152 family. Assessment of the model revealed good stereochemical quality and sequence-structure compatibility. The CD28 model was used to map surface residues, N-linked glycosylation sites, and to compare residue conservation in CD28 and CD152. The location of N-linked glycosylation sites in CD28/CD152 restricts the surface area available for binding. Rigorous sequence conservation in CD28 and CD152 is limited to core IgSF consensus positions and surface residues implicated in ligand binding. Other surface residues vary greatly in CD28/CD152. Residues critical for ligand binding are surrounded by surface patches conserved only in either CD28 or CD152.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385561     DOI: 10.1016/S1093-3263(97)00020-X

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  8 in total

1.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Authors:  J Rohr; S Guo; J Huo; A Bouska; C Lachel; Y Li; P D Simone; W Zhang; Q Gong; C Wang; A Cannon; T Heavican; A Mottok; S Hung; A Rosenwald; R Gascoyne; K Fu; T C Greiner; D D Weisenburger; J M Vose; L M Staudt; W Xiao; G E O Borgstahl; S Davis; C Steidl; T McKeithan; J Iqbal; W C Chan
Journal:  Leukemia       Date:  2015-12-31       Impact factor: 11.528

2.  Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.

Authors:  J Chen; Q He; R Zhang; Y Chu; Y Wang; Q Liu; S Xiong
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 3.  Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

Authors:  P Scheipers; H Reiser
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Inhibition of arterial allograft intimal hyperplasia using recipient dendritic cells pretreated with B7 antisense peptide.

Authors:  Yu-Feng Yao; Yi-Ming Zhou; Jian-Bin Xiang; Xiao-Dong Gu; Duan Cai
Journal:  Clin Dev Immunol       Date:  2012-02-06

5.  Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.

Authors:  Shengdian Wang; Jürgen Bajorath; Dallas B Flies; Haidong Dong; Tasuku Honjo; Lieping Chen
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

6.  CD28, costimulator or agonist receptor?

Authors:  David H Margulies
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

7.  Ligand binding sites of inducible costimulator and high avidity mutants with improved function.

Authors:  Shengdian Wang; Gefeng Zhu; Koji Tamada; Lieping Chen; Jürgen Bajorath
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

8.  Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.

Authors:  Ahmed H Badawi; Paul Kiptoo; Teruna J Siahaan
Journal:  J Mult Scler (Foster City)       Date:  2015-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.